Literature DB >> 22977278

Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.

Colin P Derdeyn1, David Fiorella, Michael J Lynn, Stanley L Barnwell, Osama O Zaidat, Philip M Meyers, Y Pierre Gobin, Jacques Dion, Bethany F Lane, Tanya N Turan, L Scott Janis, Marc I Chimowitz.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the relationship between physician and site experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial.
METHODS: Study records and an investigator survey were examined for physician and site related factors, including: number of Wingspan and aneurysm stents submitted for credentialing, number of study procedures performed in SAMMPRIS, years in practice after training, primary specialty, and site enrollment. Bivariate and multivariate analyses were performed to determine if these factors were associated with the 30 day rate of cerebrovascular events after angioplasty and stenting.
RESULTS: 213 patients underwent angioplasty alone (n=5) or angioplasty and stenting (n=208) with study devices by 63 interventionists at 48 sites. For credentialing, the median number of Wingspan and similar aneurysm stent cases submitted by study interventionists were 10 and 6, respectively. Interventionists with higher numbers (>10) of Wingspan cases submitted for credentialing tended to have higher rates of 30 day events (19.0% vs 9.9%) than those with <10 cases. High enrolling sites in the trial tended to have lower rates of hemorrhagic stroke (9.8% at sites enrolling <12 patients vs 2.7% at sites enrolling >12 patients).
CONCLUSIONS: Interventionists credentialed with less Wingspan experience were not responsible for the high rate of periprocedural stroke in SAMMPRIS. Hemorrhagic stroke may be related to low enrollment in the trial but not previous Wingspan experience.

Entities:  

Keywords:  Angioplasty; Stent; Stroke

Mesh:

Year:  2012        PMID: 22977278      PMCID: PMC3652908          DOI: 10.1136/neurintsurg-2012-010504

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  13 in total

1.  Test-based exact confidence intervals for the difference of two binomial proportions.

Authors:  I S Chan; Z Zhang
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.

Authors:  Marc I Chimowitz; Michael J Lynn; Tanya N Turan; David Fiorella; Bethany F Lane; Scott Janis; Colin P Derdeyn
Journal:  J Stroke Cerebrovasc Dis       Date:  2011 Jul-Aug       Impact factor: 2.136

3.  Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design.

Authors:  Sepideh Amin-Hanjani; Linda Rose-Finnell; DeJuran Richardson; Sean Ruland; Dilip Pandey; Keith R Thulborn; David S Liebeskind; Gregory J Zipfel; Mitchell S V Elkind; Jeffrey Kramer; Frank L Silver; Scott E Kasner; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  Int J Stroke       Date:  2010-12       Impact factor: 5.266

4.  Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine.

Authors:  Alex Abou-Chebl; Helmuth Steinmetz
Journal:  Stroke       Date:  2012-01-12       Impact factor: 7.914

5.  US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

Authors:  David Fiorella; Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Ricardo A Hanel; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

6.  Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  N Engl J Med       Date:  2011-09-07       Impact factor: 91.245

7.  Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease.

Authors:  Tanya N Turan; Leonardo Bonilha; Paul S Morgan; Robert J Adams; Marc I Chimowitz
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

Review 8.  Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease.

Authors:  Colin P Derdeyn
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

9.  The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis.

Authors:  O O Zaidat; R Klucznik; M J Alexander; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M J Lynn; M Chimowitz
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

10.  Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).

Authors:  David Fiorella; Colin P Derdeyn; Michael J Lynn; Stanley L Barnwell; Brian L Hoh; Elad I Levy; Mark R Harrigan; Richard P Klucznik; Cameron G McDougall; G Lee Pride; Osama O Zaidat; Helmi L Lutsep; Michael F Waters; J Maurice Hourihane; Andrei V Alexandrov; David Chiu; Joni M Clark; Mark D Johnson; Michel T Torbey; Zoran Rumboldt; Harry J Cloft; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2012-09-13       Impact factor: 7.914

View more
  27 in total

1.  China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.

Authors:  Peng Gao; Zhenwei Zhao; Daming Wang; Jian Wu; Yiling Cai; Tianxiao Li; Wei Wu; Huaizhang Shi; Weiwen He; Fengshui Zhu; Liqun Jiao; Feng Ling
Journal:  Interv Neuroradiol       Date:  2015-05-01       Impact factor: 1.610

Review 2.  Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Authors:  Chirantan Banerjee; Marc I Chimowitz
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Zoran Rumboldt; Harry J Cloft; Daniel Gibson; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

4.  Outcomes of middle cerebral artery angioplasty and stenting with Wingspan at a high-volume center.

Authors:  Zi-Liang Wang; Bu-Lang Gao; Tian-Xiao Li; Dong-Yang Cai; Liang-Fu Zhu; Jiang-Yu Xue; Wei-Xing Bai; Zhao-Shuo Li
Journal:  Neuroradiology       Date:  2015-10-29       Impact factor: 2.804

5.  One-pass endovascular treatment of intracranial atherosclerotic stenosis with a novel PTA balloon and self-expanding microstent.

Authors:  Markus A Möhlenbruch; Johannes Pfaff; Christian Herweh; Julian Bösel; Timolaos Rizos; Simon Nagel; Peter A Ringleb; Martin Bendszus; Mirko Pham
Journal:  Neuroradiology       Date:  2016-06-16       Impact factor: 2.804

6.  Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis.

Authors:  Shadi Yaghi; Pooja Khatri; Adam de Havenon; Sharon Yeatts; Andrew D Chang; Shawna Cutting; Brian Mac Grory; Tina Burton; Mahesh V Jayaraman; Ryan A McTaggart; David Fiorella; Colin Derdeyn; Osama O Zaidat; Seena Dehkharghani; Sepideh Amin-Hanjani; Karen Furie; Shyam Prahbakaran; David Liebeskind
Journal:  J Neurointerv Surg       Date:  2019-09-04       Impact factor: 5.836

7.  The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future.

Authors:  Marc I Chimowitz
Journal:  Stroke       Date:  2013-07-02       Impact factor: 7.914

Review 8.  Intracranial stenting: SAMMPRIS.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

Review 9.  The challenge of stroke prevention with intracranial arterial stenosis.

Authors:  Tanya N Turan; Alison Smock; Marc I Chimowitz
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

10.  Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.

Authors:  David Chiu; Richard P Klucznik; Tanya N Turan; Michael J Lynn; Charles D McCane; Lawrence B Katz; Azhar Nizam; Colin P Derdeyn; David Fiorella; Bethany F Lane; Jean Montgomery; Scott Janis; Marc I Chimowitz
Journal:  Neurology       Date:  2015-11-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.